iBio, Inc. IBIO 深 滬
已收盤 02-06 16:00:00 美东时间
2.42
+0.270
+12.56%
華盛通- 最 高2.495
- 今 開2.20
- 成交量 211.86万股
- 最 低 2.20
- 昨 收 2.15
- 總市值 7874.91万
- 52周最高 6.8908
- 市盈率 靜 --
- 換手率 6.51%
- 52周最低 0.5562
- 委 比 -90.11%
- 總股本 3254.09万
- 歷史最高 17400.00
- 量 比 1.88
- 振 幅 13.72%
- 歷史最低 0.5562
- 每 手 1
- 風險率 1.37%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026
Senti Biosciences, Inc. (Nasdaq: SNTI) announced that its CEO, Dr. Timothy Lu, will present at the Healthcare Conference Taipei 2026. The presentation on February 10, 2026, will highlight the company's Gene Circuit technology platform, pipeline progress, and strategic priorities, emphasizing partnership opportunities across investment, R&D, manufacturing, and clinical collaboration. Senti Bio, focusing on next-generation cell and gene therapies, ...
02-03 14:00
iBio Files Prospectus For Resale Of 11,061,738 Shares Of Common Stock By Selling Stockholders
11,061,738 Shares of Common StockThis prospectus relates to the resale from time to time of up to 11,061,738 shares of common stock, par value $0.001 per share (the "Common Stock") of iBio, Inc. (the "Company" or
01-31 05:24
iBio Announces Private Placement to Fund Pipeline Expansion
The latest update is out from Ibio ( ($IBIO) ). On January 8, 2026, iBio, Inc. ...
01-13 06:56
iBio announces private placement financing to raise ~$26M
iBio (IBIO) on Friday announced a securities purchase agreement with existing institutional investors for a private placement financing to raise ~$26M. Shares were +16.17% pre-market to $2.73. The bio...
01-09 20:54
iBio Announces Private Placement Of Approximately $26M
The financing was led by Frazier Life Sciences and included participation from other existing investors.iBio intends to use the net proceeds received from the offering to advance its preclinical cardiometabolic programs,
01-09 20:05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 19.2% to $1...
01-09 20:05
iBio Announces $26 Million Private Placement
iBio, Inc. has entered into a securities purchase agreement for a $26 million private placement financing with healthcare-focused institutional investors to advance its preclinical cardiometabolic programs and extend its cash runway into 2028. Frazier Life Sciences led the offering, with Leerink Partners as lead placement agent. The company will use proceeds to develop key assets and support general corporate purposes.
01-09 12:00
3 Penny Stocks to Watch Now, 12/9/25
iBio Inc. ($IBIO), iRobot ($IRBT), and Webuy Global ($WBUY) are the 3Penn...
2025-12-10 00:17
Why is Biotech Stock iBio Up over 50%?
Shares of Texas-based biotech firm iBio ($IBIO) have climbed as high as 50% ove...
2025-12-09 21:57
iBio to Participate in the 8th Annual Evercore Healthcare Conference
iBio, Inc. (NASDAQ: IBIO) announced its participation in the 8th Annual Evercore Healthcare Conference from December 2–4, 2025, in Miami. Martin Brenner, DVM, Ph.D., CEO and CSO of iBio, will discuss the company’s next-generation obesity pipeline and present non-human primate data for IBIO-610, a potential first-in-class Activin E antibody, during a fireside chat on December 4 at 8:45 a.m. ET. Felipe Duran, iBio’s CFO, will be available for one-o...
2025-11-24 21:15
